Davide Frumento | Molecular Oncology | Best Researcher Award

Prof. Davide Frumento | Molecular Oncology | Best Researcher Award

Adjunct Professor, RomaTre University, Italy

Dr. Davide Frumento is an experienced academic and researcher currently serving as an adjunct professor at Roma Tre University and Milan University in Italy. With a strong background in chemical engineering and biotechnology, he has contributed extensively to the scientific community in various research fields. His multidisciplinary expertise bridges molecular oncology, epigenetics, and biotechnology. Passionate about advancing scientific knowledge, Dr. Frumento has worked in both academic and industry settings, collaborating with top-tier institutions like Harvard University. His research is focused on innovative solutions in health, biotechnology, and environmental sustainability.

Profile

Orcid

Education 

Dr. Davide Frumento holds a PhD in Chemical Engineering from Genoa University (2012-2015), where he specialized in biotechnology applications. He graduated with a BSc and MSc in Biotechnology from the same institution (2005-2011). He further broadened his qualifications with a certification as a Scientific Expert for Criminal Procedures Court of Savona (2024). His academic journey reflects a consistent commitment to advancing his knowledge and skills, particularly in molecular sciences. Throughout his career, Dr. Frumento has continuously expanded his expertise by engaging in postdoctoral research at prominent institutions, including the University of Genoa, Milan University, and Harvard University. His extensive education has laid a strong foundation for his contributions to both academia and the industry.

Experience

Dr. Frumento has a distinguished career in academia and research. Since February 2025, he has served as an adjunct professor at the Penitentiary University Center, Milan University. He also holds a position as an adjunct professor in Epigenetics at Roma Tre University, Italy, since 2021. Previously, he has worked as a postdoctoral researcher at Genoa University, San Raffaele Hospital, and Milan University, where he contributed to research in health sciences and biotechnology. His postdoctoral research has spanned multiple departments, including DISSAL, DIMES, and DIFAR, focusing on various aspects of molecular biology, microbiota, and immunology. Dr. Frumento’s industrial experience includes a role as a Quality Control Microbiology Analyst at Noberasco SpA, further showcasing his diverse professional background. His broad expertise in both academic and industry research makes him a significant contributor to the scientific community.

Awards and Honors

Dr. Frumento’s contributions to the scientific field have earned him several prestigious awards. Notably, in 2021, he received the Smart Cup Scientific Award for Innovation and Technology from Regione Liguria, recognizing his work in health and environmental technology implementation. Earlier, in 2014, he won the Start Cup Scientific Award from the University of Genoa for his innovative work on a microtubular photobioreactor, aimed at improving microalgae culture for commercial use. His dedication to scientific innovation is also reflected in his membership in multiple scientific and technical organizations, including STRA and the Research Data Alliance. Dr. Frumento’s recognition within both the academic and industry sectors highlights his commitment to advancing research in molecular sciences, biotechnology, and environmental sustainability.

Research Focus

Dr. Frumento’s research spans several cutting-edge areas of molecular biology, with particular emphasis on biotechnology, molecular oncology, epigenetics, and environmental sciences. His work on the human microbiota’s role in immune responses and diseases such as hepatitis C and multiple sclerosis has contributed significantly to understanding their interplay. Additionally, he has explored the role of sirtuins in autoimmunity, studying SIRT6 inhibition as a therapeutic strategy for multiple sclerosis and other autoimmune diseases. Dr. Frumento’s research in the application of light-based technologies in immunotherapy further highlights his focus on innovative solutions for health and disease management. His work extends to environmental sustainability, where he investigates biotechnological applications for waste management and bioengineering, particularly in areas such as microalgae culture. By blending molecular biology with practical applications in medicine and the environment, Dr. Frumento continues to push the boundaries of scientific discovery.

Publication Top Notes

  • Interaction Between Human Microbiota, Immune System, and Hepatitis C Virus Infection: A Narrative Review 🦠
  • Light-based technologies in immunotherapy: advances, mechanisms, and applications 💡
  • Effects of Wildfire Exposure on the Human Immune System 🔥🧬
  • Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment 💊
  • Health Technology Assessment (HTA) sull’introduzione di coorti aggiuntive per la vaccinazione contro il meningococco 🦠💉
  • Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration 🧠
  • E-Muser (Enhanced Multiple Sclerosis Expected Rate): A Technical Improvement 🧑‍🔬
  • Sarcoglycanopathies: A Novel Predictive Approach 🧬
  • SIRT6 inhibition as a therapeutic approach for treating multiple sclerosis 🧠💉
  • DAI (Disease Aggressiveness Index) Implementation 📊
  • MuSER (Multiple Sclerosis Expected Rate) Predictive Model Development 🧠📈
  • Gut Microbiota Role in Liver Regeneration 🦠💡
  • Microbiota and HCV Infection Interplay 🦠
  • Oral bacteria contribution in wine flavor perception 🍷🦠
  • The efficacy of the new anti HCV therapy, implementation of a path based on the logic of micro-elimination in the Department of Mental Health and Addictions ASL4 Chiavarese 💊

 

 

Bawinile Hadebe | Breast Cancer | Best Researcher Award

Dr. Bawinile Hadebe | Breast Cancer | Best Researcher Award

Head Clinical Unit, Inkosi Albert Luthuli Central Hospital, South Africa

Dr. Bawinile Pearl-Gene Hadebe is an esteemed Nuclear Medicine specialist, currently serving as the Head of the Nuclear Medicine Department at Inkosi Albert Luthuli Central Hospital in South Africa. She is also an Honorary Lecturer at the University of KwaZulu-Natal. Bawinile holds an MBChB from the University of Cape Town, with postgraduate qualifications in Nuclear Medicine, including the FCNP(SA) and an MMed. She is pursuing a PhD in Nuclear Medicine at the University of KwaZulu-Natal. With a focus on clinical research, her work has made significant contributions to molecular imaging in oncology, particularly in oropharyngeal squamous cell carcinoma. Bawinile is known for her leadership in training future nuclear medicine specialists and her global impact as a researcher. She has been recognized with numerous awards for her research excellence and academic achievements. Her interests include jogging, traveling, and reading.

Profile

Google Scholar

Education

Dr. Bawinile Pearl-Gene Hadebe completed her medical studies at the University of Cape Town, where she earned a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree from 2002 to 2007. Her commitment to advancing her career in nuclear medicine led her to specialize in the field, and she became a Fellow of the College of Nuclear Physicians of South Africa (FCNP) in October 2015. She also holds a Master of Medicine (MMed) degree, where her research on 99mTc-MIBI scintimammography in breast cancer patients earned her significant recognition, with the abstract published in the World Journal of Nuclear Medicine. Currently, Bawinile is a PhD candidate at the University of KwaZulu-Natal, focusing on the clinical impact of 68Ga-Pentixafor in oropharyngeal squamous cell carcinoma, with a focus on HIV-infected and non-infected patients. Her academic journey has been marked by academic excellence and leadership.

Experience

Dr. Bawinile Pearl-Gene Hadebe has extensive experience in both clinical practice and academic leadership. She currently serves as the Head of the Nuclear Medicine Department at Inkosi Albert Luthuli Central Hospital, where she plays a critical role in patient care and medical education. Her past leadership roles include Acting Academic Head of Department at the University of KwaZulu-Natal’s Nuclear Medicine Department. Prior to these, she was a Specialist Nuclear Physician at Inkosi Albert Luthuli Central Hospital and Sefako Makgatho Health Sciences University. Dr. Hadebe’s experience spans both public and academic health institutions, with her expertise in nuclear medicine and imaging helping to shape the next generation of medical professionals. Additionally, she has worked at several hospitals, including Dr. George Mukhari Academic Hospital and Mmametlhake Community Hospital, contributing to a broad range of patient care and specialized research projects in nuclear medicine and oncology.

Awards and Honors

Dr. Bawinile Pearl-Gene Hadebe has received numerous prestigious awards and honors in recognition of her contributions to the field of nuclear medicine. In 2023, she was awarded the Discovery PhD Fellowship Award, a significant recognition for her ongoing research in molecular imaging and oncology. She also secured the SAMRC self-initiated research fund, providing R200,000 per year for three years (2023–2025) to advance her research. Her groundbreaking work on nuclear imaging techniques has earned her the Vulindlela Holdings research grant of R45,000 for her PhD research. Dr. Hadebe has also earned international accolades, winning the Best International Abstract Award for South Africa at the SNMMI meeting in Toronto (June 2024) and the Best Abstract Award at the iPET meeting in Vienna (October 2024). Her expertise has led to her selection as an international expert at the International Atomic Energy Agency (IAEA) regional training course in Cairo, Egypt, in August 2024.

Research Focus

Dr. Bawinile Pearl-Gene Hadebe’s research primarily focuses on the application of nuclear medicine and molecular imaging in oncology, specifically in the diagnosis and management of cancers such as oropharyngeal squamous cell carcinoma (SCC). Her PhD research explores the clinical impact of 68Ga-Pentixafor PET/CT in evaluating CXCR-4 expression in oropharyngeal SCC in both HIV-infected and non-infected patients. The aim is to assess the diagnostic performance of this molecular imaging technique in the context of KwaZulu-Natal’s unique healthcare challenges. In addition, her earlier work, such as the role of 99mTc-MIBI scintimammography in breast cancer diagnosis, has demonstrated the utility of nuclear medicine in improving the detection and management of malignancies. Dr. Hadebe’s research is not only scientifically significant but also highly relevant to addressing the healthcare needs in resource-constrained settings.

Publication Top Notes

  • Current Status of 68Ga-Pentixafor in Solid Tumours 🧬🩺
  • Molecular Imaging and Theranostics in Ovarian Cancer: The Role of Nuclear Medicine 🔬💉
  • The Clinical Utility of 2-deoxy-2-[18F] Fluoro-d-glucose Positron Emission Tomography in Guiding Myocardial Revascularisation 🫀📊
  • The Role of 99m Tc-Mibi Scintimammography in Predicting Malignancy in Patients Suspected to Have Fibroadenomas of the Breast on Mammography 🩻👩‍⚕️
  • Assessing the Diagnostic Accuracy of 99mTc-MIBI Scintimammography in Predicting Malignancy in Patients Suspected to Have Fibroadenomas of the Breast 🩻🔍